🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the effectiveness of lanreotide aut...
Status
Completed
Location
Baptist Health System Inc
Start Date
2000-05
Trial ID
NCT00234572
Treatments Being Tested
The purpose of the protocol is to evaluate the correlation between plasma l...
Status
Withdrawn
Location
Centro Médico Nacional Siglo XXI, IMSS
Start Date
2008-05
Trial ID
NCT00517491
Treatments Being Tested
The primary purpose of this extension study was to assess the long term saf...
Status
Completed
Location
Cedars-Sinai Outpatient Cancer Center
Start Date
2009-02
Trial ID
NCT00842348
Treatments Being Tested
The main aim of this study is to assess the efficacy of the co-administrati...
Status
Completed
Location
University Hospital, Charles University
Start Date
2006-10
Trial ID
NCT00383708
Treatments Being Tested
The purpose of this study is to assess the efficacy, safety and patient acc...
Status
Completed
Location
Westmead Hospital
Start Date
2004-06
Trial ID
NCT00216398
Treatments Being Tested
The primary objective of the study is to evaluate the impact on quality of ...
Status
Terminated
Location
Ospedale Sacro Cuore di Gesù, U.O.C. Oncologia Medica
Start Date
2015-01
Trial ID
NCT02365584
Treatments Being Tested
The objectives of the protocol is to determine the maximum tolerated dose a...
Status
Completed
Location
Antwerp University Hospital
Start Date
2015-03
Trial ID
NCT02396953
Treatments Being Tested
The purpose of this study is to allow patients with acromegaly, or their pa...
Status
Completed
Location
Michael White Centre Diabetes & Endocrinology, Hull Royal Infirmary
Start Date
2004-02
Trial ID
NCT00149188
Treatments Being Tested
This is a Phase 3, prospective, multi-center, randomized, double-blind, stu...
Status
Terminated
Location
Arizona Oncology Associates
Start Date
2017-03-06
Trial ID
NCT02683941
Treatments Being Tested
The purpose of the protocol, is to evaluate if lanreotide Autogel 120 mg is...
Status
Completed
Location
Ospedali Riuniti di Bergamo
Start Date
2001-01
Trial ID
NCT00499993
Treatments Being Tested